Related Experiment Video
Updated: Jul 14, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
"Thinking without thinking" about natalizumab and PML.
1Neuroinflammation Research Center, Department of Neurosciences, The Lerner Research Institute, The Cleveland Clinic Foundation, United States.
Natalizumab, a multiple sclerosis (MS) therapy, was linked to progressive multifocal leukoencephalopathy (PML). This suggests PML may be mechanism-based, not due to general immunosuppression in MS patients.
Area of Science:
- Neuroimmunology
- Clinical Neurology
- Pharmacology
Background:
- Natalizumab is an effective therapy for multiple sclerosis (MS).
- Its use was complicated by the emergence of progressive multifocal leukoencephalopathy (PML).
- PML cases were observed in clinical trial participants, leading to a temporary suspension of the drug.
Purpose of the Study:
- To propose a hypothesis for the mechanism of PML in natalizumab-treated patients.
- To differentiate PML from generalized immunosuppression-related opportunistic infections.
Main Methods:
- Review of clinical data and adverse event reports.
- Analysis of the potential mechanism of action of natalizumab.
- Comparison of PML occurrence with other opportunistic infections.
Main Results:
- Natalizumab treatment was not associated with increased opportunistic infections, apart from PML.
- This observation suggests a specific mechanism rather than broad immunosuppression.
Conclusions:
- PML in natalizumab-treated patients is likely a mechanism-based adverse event.
- Further research is needed to elucidate the precise mechanism linking natalizumab to PML.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Cryptococcal Meningitis
Multiple Sclerosis l: Introduction
Cytomegalovirus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

